|
|
|
197A TAUNS Laboratories,Inc.
|
|
| 06/26/2025 17:00 |
Notice regarding Selection of Our Company's Shares as Loan Margin Trading Issue |
| 05/14/2025 15:30 |
Financial Highlightsfor 3Qended March 31, 2025 |
| 05/14/2025 15:30 |
Financial Results for the Nine Months Ended March 31, 2025 (Japanese Accounting Standards) |
| 05/09/2025 15:30 |
(Update on Disclosed Matters) Notice regarding Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange |
| 04/28/2025 11:00 |
TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests fo |
| 04/04/2025 18:00 |
Notice of Capital and Business Alliance with Aillis, Inc. and Acquisition of Shares through Third-Party Allocation of New Shares. |
| 04/01/2025 15:30 |
TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes |
| 02/13/2025 15:30 |
Financial Highlights for 2Q ended December 31, 2024 |
| 02/13/2025 15:30 |
Financial Results for the SIX Months Ended December 31, 2024 (Japanese Accounting Standards) |
| 02/06/2025 15:30 |
Notice of Strategic Business Alliance with ZACROS Corporation |
| 01/28/2025 15:30 |
Patent on Method and Reagent for Detecting Target Substance Granted in Japan |
| 01/22/2025 15:30 |
(Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K. |
| 12/25/2024 15:30 |
Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K. |
| 12/13/2024 15:30 |
Notice regarding Preparation for Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange |
| 11/13/2024 15:30 |
Supplementary Material on Financial Results for the Three Months Ended September 30, 2024 |
| 11/13/2024 15:30 |
Financial Results for the Three Months Ended September 30, 2024 (Japanese Accounting Standards) |
| 10/31/2024 15:30 |
Announcement of Participation in the Triple I for Global Health (Impact Investment Initiative for Global Health) |
| 10/24/2024 15:30 |
Announcement of Conclusion of License Agreement with First Screening Corp. |
| 10/16/2024 15:30 |
Announcement of Acquisition of "Kurumin" Certification as a Child-Rearing Support Company |
| 09/26/2024 15:30 |
Notice of Personnel Changes |
| 09/03/2024 08:00 |
Notice of the 9th Ordinary General Meeting of Shareholders |
| 08/13/2024 15:30 |
FY2024 Financial Results (Japanese Accounting Standards) |
| 08/02/2024 15:00 |
Announcement of the Strategic Capital and Business Alliance between TAUNS Laboratories, Inc. and Connect Afya Ltd. |
|
